Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Conditioning for acute myeloid leukemia: looking beyond intensity.
Journal: Haematologica
Published: March 04, 2026
Known Prognostic Models Fail to Predict Outcomes for Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis.
Journal: American journal of hematology
Published: May 14, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United States.
Journal: Blood neoplasia
Published: January 02, 2025
Recombinant Myeloid Hematopoietic Growth Factors and Clinical Stimulation of Acute Myeloid Leukemia Cells: A Narrative Review.
Journal: Acta haematologica
Published: December 21, 2024
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?
Journal: American journal of hematology
Published: June 01, 2024
Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia.
Journal: Blood neoplasia
Published: November 13, 2023
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis.
Journal: Leukemia research
Published: March 21, 2023
Showing 1-7 of 7
Last Updated: 09/26/2026